Pioneering the Next Generation
of Precision ADC Therapeutics
We aim to deliver new life-saving therapies for patients with cancer and rare disease. Built by a dynamic team of serial entrepreneurs and expert scientists and drug developers, we are advancing innovative medicines targeting highly specific molecular drivers of disease.
Eric Murphy, Ph.D.
/in Leadership TeamChief Executive Officer,
Co-Founder, & Director
Rob McRae
/in Leadership TeamPresident &
Chief Operating Officer
Patrick A. Zweidler-McKay, M.D., Ph.D.
/in Leadership TeamChief Medical Officer
Leslie Sharp, Ph.D.
/in Leadership TeamChief Scientific Officer
Michael Mueller
/in Leadership TeamGeneral Counsel